Luca D’Onofrio

1.7k total citations
52 papers, 1.1k citations indexed

About

Luca D’Onofrio is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Molecular Biology. According to data from OpenAlex, Luca D’Onofrio has authored 52 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Endocrinology, Diabetes and Metabolism, 11 papers in Genetics and 10 papers in Molecular Biology. Recurrent topics in Luca D’Onofrio's work include Diabetes and associated disorders (10 papers), Bone health and osteoporosis research (7 papers) and Pancreatic function and diabetes (6 papers). Luca D’Onofrio is often cited by papers focused on Diabetes and associated disorders (10 papers), Bone health and osteoporosis research (7 papers) and Pancreatic function and diabetes (6 papers). Luca D’Onofrio collaborates with scholars based in Italy, United Kingdom and Qatar. Luca D’Onofrio's co-authors include Andrea Palermo, Nicola Napoli, Paolo Pozzilli, Silvia Manfrini, Raffaella Buzzetti, Ernesto Maddaloni, Dario Tuccinardi, Giuseppe Defeudis, Mikiko Watanabe and Rocky Strollo and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

Luca D’Onofrio

49 papers receiving 1.1k citations

Peers

Countries citing papers authored by Luca D’Onofrio

Since Specialization

Citations

This map shows the geographic impact of Luca D’Onofrio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luca D’Onofrio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luca D’Onofrio more than expected).

Fields of papers citing papers by Luca D’Onofrio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luca D’Onofrio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luca D’Onofrio. The network helps show where Luca D’Onofrio may publish in the future.

Co-authorship network of co-authors of Luca D’Onofrio

This figure shows the co-authorship network connecting the top 25 collaborators of Luca D’Onofrio. A scholar is included among the top collaborators of Luca D’Onofrio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luca D’Onofrio. Luca D’Onofrio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Osteocalcin is inversely associated with worse adipose tissue distribution and cardiovascular risk in autoimmune diabetes 2025 ·Diabetes Research and Clinical Practice ·Renata Risi, (unknown), Angela Balena, Mikiko Watanabe, Davide Masi, Valeria Fassino, (unknown), Luca D’Onofrio, Angelo Lauria, Simona Zampetti, Lucio Gnessi, Ernesto Maddaloni, Raffaella Buzzetti	0
2	IFN-α Neutralizing Antibodies Distinguish LADA From Early-onset Type 1 Diabetes 2025 ·The Journal of Clinical Endocrinology & Metabolism ·(unknown), Luca D’Onofrio, (unknown), Stefano Di Giulio, Carmen Mignogna, (unknown), (unknown), Simona Zampetti, Ilaria Malandrucco, Paolo Pozzilli, Giuseppe Giannini, Ernesto Maddaloni, Raffaella Buzzetti	1
3	Residual C-peptide secretion is associated with better CGM-metrics in adults with short-lasting type 1 diabetes 2025 ·Diabetes Research and Clinical Practice ·(unknown), Simona Zampetti, (unknown), Luca D’Onofrio, Francesco De Vita, (unknown), (unknown), (unknown), (unknown), Renata Risi, Ernesto Maddaloni, Raffaella Buzzetti	3
4	Liver disease in people with latent autoimmune diabetes in adults (LADA): A cross-sectional study using magnetic resonance elastography 2025 ·Diabetes Research and Clinical Practice ·Ernesto Maddaloni, Marta Zerunian, Vincenzo Cardinale, (unknown), (unknown), (unknown), Renata Risi, Luca D’Onofrio, (unknown), (unknown), Damiano Caruso, Domenico Alvaro, Andrea Laghi, Raffaella Buzzetti	0
5	No Differences in Kidney Function Decline Between People With Type 2 Diabetes Starting a Sodium-Glucose Cotransporter 2 Inhibitor or a Glucagon-like Peptide-1 Receptor Agonist: A Real-world Retrospective Comparative Observational Study 2024 ·Clinical Therapeutics ·(unknown), (unknown), Luca D’Onofrio, Carmen Mignogna, (unknown), (unknown), (unknown), (unknown), Raffaella Buzzetti, (unknown)	2
6	Deterioration of Vestibular Motion Perception: A Risk Factor for Postural Instability and Falls in Elderly With Type 2 Diabetes 2024 ·Diabetes/Metabolism Research and Reviews ·Barbara La Scaleia, (unknown), Luca D’Onofrio, (unknown), (unknown), (unknown), (unknown), Ernesto Maddaloni, Simona Zampetti, Raffaella Buzzetti, Myrka Zago, Francesco Lacquaniti	3
7	Spinal disinhibition: evidence for a hyperpathia phenotype in painful diabetic neuropathy 2023 ·Brain Communications ·Anne Marshall, Alise Kalteniece, Maryam Ferdousi, Shazli Azmi, Edward B. Jude, (unknown), Luca D’Onofrio, Shaishav Dhage, Handrean Soran, J. A. Campbell, Corinne A. Lee-Kubli, Shaheen Hamdy, Rayaz A. Malik, Nigel A. Calcutt, Andrew Marshall	9
8	Impact of baseline kidney function on the effects of sodium‐glucose co‐transporter‐2 inhibitors on kidney and heart failure outcomes: A systematic review and meta‐analysis of randomized controlled trials 2023 ·Diabetes Obesity and Metabolism ·Ernesto Maddaloni, Ilaria Cavallari, (unknown), (unknown), Luca D’Onofrio, Francesco Grigioni, Raffaella Buzzetti, Rury R. Holman	13
9	Association of osteocalcin, osteoprotegerin, and osteopontin with cardiovascular disease and retinopathy in type 2 diabetes 2023 ·Diabetes/Metabolism Research and Reviews ·Ernesto Maddaloni, (unknown), (unknown), Marco Giorgio Baroni, Maria Gisella Cavallo, Massimiliano Copetti, Efisio Cossu, (unknown), Luca D’Onofrio, Salvatore De Cosmo, Frida Leonetti, Susanna Morano, (unknown), Nicola Napoli, Sabrina Prudente, Giuseppe Pugliese, Kyoungmin Park, Rury R. Holman, Vincenzo Trischitta, Raffaella Buzzetti, (unknown)	12
10	Third dose of COVID‐19 vaccine in diabetes: Relevance of good metabolic control to improve its efficacy 2022 ·Diabetes/Metabolism Research and Reviews ·Silvia Pieralice, Luca D’Onofrio, Paolo Pozzilli, Raffaella Buzzetti	5
11	The Sodium–Glucose Co-Transporter-2 (SGLT2) Inhibitors Reduce Platelet Activation and Thrombus Formation by Lowering NOX2-Related Oxidative Stress: A Pilot Study 2022 ·Antioxidants ·Pasquale Pignatelli, Francesco Baratta, Raffaella Buzzetti, Alessandra D’Amico, Valentina Castellani, Simona Bartimoccia, (unknown), Luca D’Onofrio, Ernesto Maddaloni, Annachiara Pingitore, Giovanni Alfonso Chiariello, Francesca Santilli, Daniele Pastori, Nicholas Cocomello, Francesco Violi, Maria Del Ben, Vittoria Cammisotto, Roberto Carnevale	21
12	Corneal confocal microscopy identifies small nerve fibre damage in patients with hypertriglyceridemia 2022 ·Journal of clinical lipidology ·Luca D’Onofrio, Maryam Ferdousi, Alise Kalteniece, Zohaib Iqbal, Ioannis N. Petropoulos, Georgios Ponirakis, Raffaella Buzzetti, Rayaz A. Malik, Handrean Soran	12
13	Impact of cardiovascular disease on clinical outcomes in hospitalized patients with Covid-19: a systematic review and meta-analysis 2021 ·Internal and Emergency Medicine ·Ernesto Maddaloni, Luca D’Onofrio, (unknown), (unknown), Carmen Mignogna, (unknown), Ilaria Cavallari, Francesco Grigioni, Raffaella Buzzetti	6
14	Risk of cardiac autonomic neuropathy in latent autoimmune diabetes in adults is similar to type 1 diabetes and lower compared to type 2 diabetes: A cross‐sectional study 2020 ·Diabetic Medicine ·Ernesto Maddaloni, Chiara Moretti, (unknown), (unknown), (unknown), (unknown), Rocky Strollo, Silvia Briganti, Luca D’Onofrio, Paolo Pozzilli, Raffaella Buzzetti	13
15	Clinical, Biochemical, and Radiological Profile of Normocalcemic Primary Hyperparathyroidism 2020 ·The Journal of Clinical Endocrinology & Metabolism ·Andrea Palermo, Anda Mihaela Naciu, Gaia Tabacco, (unknown), Assunta Santonati, Daria Maggi, Luca D’Onofrio, Silvia Briganti, (unknown), Alessandro Casini, Claudio Pedone, Diana Lelli, Andrea Fabbri, John P. Bilezikian, Nicola Napoli, Paolo Pozzilli, Silvia Manfrini, Roberto Cesareo	43
16	Alpha-tocopherol and contrast-induced nephropathy: A meta-analysis of randomized controlled trials 2019 ·International Journal for Vitamin and Nutrition Research ·Matteo Monami, Angelo Cignarelli, Sara Pinto, Luca D’Onofrio, Agostino Milluzzo, Roberto Miccoli, Giuseppe Penno, Edoardo Mannucci	10
17	Wrist circumference is a biomarker of adipose tissue dysfunction and cardiovascular risk in children with obesity 2019 ·Journal of Endocrinological Investigation ·(unknown), Ernesto Maddaloni, Carla Bizzarri, Stefania Pedicelli, Simona Zampetti, Luca D’Onofrio, Chiara Moretti, Marco Cappa, Raffaella Buzzetti	15
18	Pathophysiology of Bone Fragility in Patients with Diabetes 2017 ·Calcified Tissue International ·Andrea Palermo, Luca D’Onofrio, Raffaella Buzzetti, Silvia Manfrini, Nicola Napoli	77
19	Oral anti-diabetic drugs and fracture risk, cut to the bone: safe or dangerous? A narrative review 2015 ·Osteoporosis International ·Andrea Palermo, Luca D’Onofrio, Richard Eastell, Ann V. Schwartz, Paolo Pozzilli, Nicola Napoli	79
20	Severe Hypophosphatemic Osteomalacia Secondary to Fanconi Syndrome Due to Adefovir: A Case Report 2014 ·Endocrine Practice ·Andrea Palermo, Rocky Strollo, Rocco Papalia, Luca D’Onofrio, Ernesto Maddaloni, Silvia Briganti, Nicola Napoli, Umberto Vespasiani‐Gentilucci, Sebastiano Costantino, Paolo Pozzilli, Vincenzo Denaro, Silvia Manfrini	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact